Athauda, Dilan
Foltynie, Thomas
Article History
First Online: 31 July 2018
Compliance with Ethical Standards
:
: DA received funding from the Cure Parkinson’s Trust. No funding was received specifically for the publication of this review.
: DA has no conflicts of interest. TF has received honoraria from Profile Pharma, BIAL, AbbVie, Genus, Medtronic, and St Jude Medical. DA and TF are investigators on the Exenatide-PD trial.